Paxlovid didn’t provide any benefit in a placebo-controlled randomized trial in lower risk (mean age 42 years) outpatients with mild-to-moderate Covid
@erictopol and wow o wow are they pushing commercials of this product on paramount +
@sergiodomeyko @erictopol it's effective for high-risk patients for a severe systemic infection